Finance
On September 25, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will & Schulte’s annual Healthcare Private Equity (HPE) Europe conference. Keynote speakers Steph McGovern and Robert Peston, hosts of the hit UK podcast The Rest Is Money covering money, politics, and the markets, kicked off a high-impact event with remarks from [...]
With funding rebounding, Odgers’ Chris Hamilton and Mike Drew explain what investors are looking for in health tech leadership teams After a sharp downturn, funding in digital health is beginning to rebound. According to Galen Growth, global digital health venture funding climbed back to $25.1 billion in 2024, a 5.5 per cent year-over-year increase after [...]
By Reddie & Grose It is impossible to escape the headlines on GLP-1 agonists such as Ozempic and Wegovy. Therefore, it seems reasonable to assume that the innovator behind these blockbuster drugs has robust, fail-safe strategies to protect their intellectual property worldwide. However, inaction by Danish company Novo Nordisk, who manufactures Ozempic and Wegovy, has [...]
Pharmaceutical companies have paused or cancelled nearly £2bn in planned UK investments this year, causing “suffering” to patients, as disputes over drug pricing escalate ahead of talks with Trump, The Guardian reports. The life sciences sector crisis deepened after US drugmaker MSD said last Wednesday it would abandon its £1bn London research centre. Two days [...]
Biotechnology company kyron.bio today announced a €5.5 million funding round. The seed funding round was led by HCVC, with the participation of Verve Ventures, Entrepreneur First, Saras Capital, and numerous reputable angel investors. The funds will accelerate the development of kyron.bio’s proprietary glycan-engineering platform, expand the kyron.bio team and fuel preclinical studies. Additionally, the funding [...]
Why silence is not a strategy – It’s a risk By Fern Lazar, Managing Partner, Global Health Practice Leader at FINN Partners When the biotech market is booming, even companies that whisper are heard. Capital flows freely, IPOs are plentiful, and early-stage promises often ride the wave of sector momentum. But in a slump — [...]
Healthcare technology companies worldwide secured major investment this month, from seed rounds to strategic partnerships. Nigeria’s Platos Health raises US$1.4m for metabolic health platform Lagos-based Platos Health closed a US$1.4m pre-seed round to expand its AI-powered metabolic health platform, Platos 3.0. The raise highlights growing investor interest in Africa’s digital health sector, with support from [...]
Brain disease-focused biopharma Neomora Therapeutics is facing a potential law suit over claims it misled shareholders who took part in its US£250m IPO in 2023. Law firm Robbins LLP is investigating allegations that it misled investors in the offering of documents which supported its IPO. Since the IPO, the value of Neumora common stock has [...]
Health Tech World explores the latest investment developments in the world of healthcare. US$8m to advance AI-powered early cancer detection C the Signs, the creator of an AI-based platform to identify patients at risk of cancer at the earliest and most curable stage, has received US$8m in funding from Khosla Ventures. The new capital will [...]
Ablatus, creators of women-led medical device company Luna has announced the launch of a crowdfunding campaign aimed at raising additional funds for its Luna treatment. The company's patented core ablation technology lays the groundwork for a minimally invasive solution in treating uterine fibroids that aims to transform women's health globally. Afer security £3 million of [...]
